Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeMuRu-OKA Vaccine Administration Route Study
NCT00351923Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of GSK208136 in measles, mumps, rubella and 1 more (2 arms), sponsored by GSK. Primary endpoint: Seroconversion rates after vaccination. Started Mar 2006; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellachickenpox
Beyond the preview
Go deeper on NCT00351923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351923.